0001209191-13-023684.txt : 20130502
0001209191-13-023684.hdr.sgml : 20130502
20130502164308
ACCESSION NUMBER: 0001209191-13-023684
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130430
FILED AS OF DATE: 20130502
DATE AS OF CHANGE: 20130502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INVACARE CORP
CENTRAL INDEX KEY: 0000742112
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 952680965
STATE OF INCORPORATION: OH
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE INVACARE WAY
STREET 2: P O BOX 4028
CITY: ELYRIA
STATE: OH
ZIP: 44036
BUSINESS PHONE: 4403296000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SLANGEN LOUIS F J
CENTRAL INDEX KEY: 0001233925
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
STATE OF INCORPORATION: OH
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15103
FILM NUMBER: 13808773
BUSINESS ADDRESS:
STREET 1: ONE INVACARE WAY
STREET 2: P O BOX 4028
CITY: ELYRIA
STATE: OH
ZIP: 44036
BUSINESS PHONE: 4403296000
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-04-30
0
0000742112
INVACARE CORP
IVC
0001233925
SLANGEN LOUIS F J
ONE INVACARE WAY
ELYRIA
OH
44035
0
1
0
0
Senior Vice President
Common Shares
2013-04-30
4
P
0
1000
13.0463
A
36495
D
Common Shares
10433
I
By Invacare Retirement Savings Plan
Common Shares
522
I
By Spouse
Employee Stock Option (Right to Buy)
Common Shares
176800
176800
D
Owned by the Trustee for the Invacare Retirement Savings Plan. The information given is based on a Plan Statement of April 30, 2013, the most recent information reasonably available.
No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
The reporting person holds previously reported options to buy 176,800 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between August 20, 2003 and March 18, 2013, at exercise prices between $13.37 to $44.30 per share, will expire between August 20, 2013 and March 18, 2023 and became or will become exercisable between September 30, 2004 and March 31, 2017.
/s/ Louis F. J. Slangen, by Kristofer K. Spreen, his attorney-in-fact pursuant to Power of Attorney, dated February 12, 2009, on file with the Commission
2013-05-02